These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 8885147)

  • 1. Effect of multimerization of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII.
    Fischer BE; Kramer G; Mitterer A; Grillberger L; Reiter M; Mundt W; Dorner F; Eibl J
    Thromb Res; 1996 Oct; 84(1):55-66. PubMed ID: 8885147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and functional characterization of recombinant von Willebrand factor produced on a large scale.
    Fischer BE; Schlokat U; Reiter M; Mundt W; Dorner F
    Cell Mol Life Sci; 1997 Dec; 53(11-12):943-50. PubMed ID: 9447247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of 25 monoclonal antibodies to factor VIII-von Willebrand factor: relationship between ristocetin-induced platelet aggregation and platelet adherence to subendothelium.
    Stel HV; Sakariassen KS; Scholte BJ; Veerman EC; van der Kwast TH; de Groot PG; Sixma JJ; van Mourik JA
    Blood; 1984 Jun; 63(6):1408-15. PubMed ID: 6426553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII.
    Wise RJ; Dorner AJ; Krane M; Pittman DD; Kaufman RJ
    J Biol Chem; 1991 Nov; 266(32):21948-55. PubMed ID: 1939217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen.
    Sixma JJ; Sakariassen KS; Stel HV; Houdijk WP; In der Maur DW; Hamer RJ; de Groot PG; van Mourik JA
    J Clin Invest; 1984 Sep; 74(3):736-44. PubMed ID: 6332119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
    Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
    J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of the von Willebrand factor domain interacting with platelet glycoprotein Ib, heparin, and collagen and characterization of its three distinct functional sites.
    Mohri H; Yoshioka A; Zimmerman TS; Ruggeri ZM
    J Biol Chem; 1989 Oct; 264(29):17361-7. PubMed ID: 2477370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factor.
    Neugebauer BM; Goy C; Budek I; Seitz R
    Semin Thromb Hemost; 2002 Apr; 28(2):139-48. PubMed ID: 11992237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
    Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of deletion of the A1 domain of von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetin.
    Sixma JJ; Schiphorst ME; Verweij CL; Pannekoek H
    Eur J Biochem; 1991 Mar; 196(2):369-75. PubMed ID: 1901037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of von Willebrand Factor and its proteolytic fragments on kinetics of interaction between the light and heavy chains of human factor VIII.
    Saenko EL; Loster K; Josic D; Sarafanov AG
    Thromb Res; 1999 Dec; 96(5):343-54. PubMed ID: 10605949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a plasma- and albumin-free recombinant von Willebrand factor.
    Turecek PL; Mitterer A; Matthiessen HP; Gritsch H; Varadi K; Siekmann J; Schnecker K; Plaimauer B; Kaliwoda M; Purtscher M; Woehrer W; Mundt W; Muchitsch EM; Suiter T; Ewenstein B; Ehrlich HJ; Schwarz HP
    Hamostaseologie; 2009 Oct; 29 Suppl 1():S32-8. PubMed ID: 19763356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Von Willebrand factor in the vessel wall mediates platelet adherence.
    Stel HV; Sakariassen KS; de Groot PG; van Mourik JA; Sixma JJ
    Blood; 1985 Jan; 65(1):85-90. PubMed ID: 3917314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.
    Kao KJ; Pizzo SV; McKee PA
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5317-20. PubMed ID: 315561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lectin activity of the coagulation factor VIII/von Willebrand complex.
    Santizo F; Zenteno E; Pina-Canseco S; Hernandez-Cruz P; Cruz MM; Mayoral LP; Pérez-Campos E; Martínez-Cruz R
    Tohoku J Exp Med; 2009 Mar; 217(3):209-15. PubMed ID: 19282656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagen-bound von Willebrand factor has reduced affinity for factor VIII.
    Bendetowicz AV; Wise RJ; Gilbert GE
    J Biol Chem; 1999 Apr; 274(18):12300-7. PubMed ID: 10212199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factor.
    Kroner PA; Foster PA; Fahs SA; Montgomery RR
    Blood; 1996 Feb; 87(3):1013-21. PubMed ID: 8562925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mutation Arg (53)----Trp causes von Willebrand disease Normandy by abolishing binding to factor VIII. Studies with recombinant von Willebrand factor.
    Jorieux S; Tuley EA; Gaucher C; Mazurier C; Sadler JE
    Blood; 1992 Feb; 79(3):563-7. PubMed ID: 1732004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new method measuring the interaction between von Willebrand factor and coagulation factor VIII.
    Karlman M; Holmström M; Wiman B
    Thromb Res; 2011 Jan; 127(1):47-50. PubMed ID: 21094987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for the C2 domain of factor VIII in binding to von Willebrand factor.
    Saenko EL; Shima M; Rajalakshmi KJ; Scandella D
    J Biol Chem; 1994 Apr; 269(15):11601-5. PubMed ID: 7512568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.